China Resources Pharmaceutical Group Ltd. (HK:3320) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
China Resources Pharmaceutical Group Ltd. has increased its stake in Dong-E-E-Jiao by 1% through its subsidiary, CR Pharmaceutical Investment. The group now controls approximately 33.58% of Dong-E-E-Jiao and plans to boost its shareholding further by up to 1.2% over the next six months. This move is aimed at reinforcing investor confidence and supporting the stable growth of the company.
For further insights into HK:3320 stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- Apple and Nvidia Partner to Enable Faster LLM Token Generation
- Amazon Faces Largest Teamsters Strike to Date in Busy Christmas Season
- ‘Time to Move to the Sidelines,’ Says Analyst About Rivian Stock
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
